Pharmafile Logo

Evotec CEO Werner Lanthaler temporarily stands down

Cites health reasons

Evotec’s CEO Dr Werner Lanthaler, has temporarily stood down from his role within the company due to health reasons.

Dr Lanthaler informed the supervisory board of his situation, and the board approved approved his leave of absence. It also wished Dr Lanthaler an early recovery.

The management board of Dr Cord Dohrmann and Colin Bond, under the direction of Dr Mario Polywka, the chief operating officer, will lead the company in the absence of Dr Lanthaler.

He will reassume the role of CEO as soon as he has recovered.

Article by Tom Meek
5th October 2012
From: Research
Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links